Global Cholesterol Testing Market Based on Product Type Segmented Into Testing Strips and Test Kits with 58.7% Market Share

The Global Cholesterol Testing Market is expected to reach USD 2,572.27 million by 2025, from USD 1,408.99 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025.

The major factors driving the market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare, increasing cholesterol home/self-testing market.

To Get a Free Sample @  https://tinyurl.com/y7g8daev

Global-Cholesterol-Testing-Market
Global-Cholesterol-Testing-Market

The key market players for Global Cholesterol Testing Market are listed below:

  • Abbott Laboratories
  • Accutech, LLC
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Prima Lab SA
  • Quest Diagnostics, Inc.
  • Home Access Health Corporation
  • Hoffmann-La Roche AG
  • Siemens AG
  • Sigma-Aldrich Corp.

The market is  segmented into:

  • Product Type
  • Test
  • Test Type
  • Prescription Mode
  • End-users

Have Any Query? Speak To Our Expert @ https://tinyurl.com/ydzasxuw

The global Cholesterol Testing Market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The Global cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits are expected to dominate the global cholesterol testing market with 58.7% market share and are expected to reach USD 6,119.56 million by 2025, with the highest CAGR of 7.9 % in the forecast period 2018 to 2025.

The Global cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile are expected to dominate the global cholesterol testing market with 35.3% market share and are expected to reach USD 3,778.31 million by 2025, with the highest CAGR of 8.3% in the forecast period 2018 to 2025.

The Global cholesterol testing market is segmented on the basis of test type into non-invasive and invasive. The invasive are expected to reach USD 7,131.55 million by 2025, from USD 4,032.26 million in 2017, growing at a CAGR of 7.5%. However, non-invasive is growing at the highest CAGR of 8.2% and is expected to reach USD 3,159.02 million by 2025.

The Global Cholesterol Testing Market is segmented on the basis of prescription mode into over the counter and prescription based. In 2018, prescription-based are expected to dominate the global cholesterol testing market with 76.9% market share and is expected to reach USD 8,059.07 million by 2025, with the highest CAGR of 8.0% in the forecast period 2018 to 2025.

The Global cholesterol testing market is segmented on the basis of prescription mode into end users, clinics, hospitals, ambulatory centers, homecare and diagnostic centers. In 2018, hospitals segment is expected to dominate the global cholesterol testing market with 35.0% market share and is expected to reach USD 4,233.71 million by 2025, with the highest CAGR of 8.5% in the forecast period 2018 to 2025.

Based on geography, the Global cholesterol testing market is segmented into geographical regions, such as,

  • North- America,
  • South America
  • Global
  • Asia-Pacific
  • Middle East and Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global cholesterol testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS GLOBAL CHOLESTEROL TESTING MARKET

  1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY

1.2. MARKET DEFINITION

1.3. OVERVIEW OF GLOBAL CHOLESTEROL TESTING MARKET

1.4. CURRENCY AND PRICING

1.5. LIMITATION

1.6. MARKETS COVERED

  1. MARKET SEGMENTATION

2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7. SECONDARY SOURCES

2.8. ASSUMPTIONS

  1. EXECUTIVE SUMMARY
  2. MARKET OVERVIEW

4.1. DRIVERS

4.1.1. TECHNOLOGICAL ADVANCEMENTS IN CHOLESTEROL TESTING

4.1.2. GROWING NUMBER OF CARDIOVASCULAR DISEASES AND OBESITY

4.1.3. HIGHER GROWING NUMBER OF GERIATRIC POPULATION

4.1.4. RISING AWARENESS AND ACCEPTANCE OF PREVENTIVE HEALTHCARE

4.1.5. INCREASING CHOLESTEROL HOME/SELF-TESTING MARKET

4.2. RESTRAINTS

4.2.1. LACK OF KNOWLEDGE ABOUT NEW TREATMENT PRACTICES

4.2.2. REGULATORY POLICIES

4.3. OPPORTUNITIES

4.3.1. HIGH GROWTH POSSIBILITY IN DEVELOPING COUNTRIES

4.3.2. PATIENT-INITIATED TESTING

4.4. CHALLENGES

4.4.1. PATIENT DATA SECURITY

  1. PREMIUM INSIGHTS
  2. GLOBAL CHOLESTEROL TESTING MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

6.2. TESTING STRIPS

6.3. TEST KITS

  1. GLOBAL CHOLESTEROL TESTING MARKET, BY TEST

7.1. OVERVIEW

7.2. LIPID PANEL TEST/COMPLETE LIPID PROFILE

7.2.1. TOTAL CHOLESTEROL TEST

7.2.2. HDL CHOLESTEROL TEST

7.2.3. LDL CHOLESTEROL TEST

7.2.4. TRIGLYCERIDES/VLDL CHOLESTEROL TEST

7.3. APOLIPOPROTEIN B TEST

7.4. APOLIPOPROTEIN A-1 TEST

7.5. APOE GENOTYPING TEST

7.6. APOLIPOPROTEIN CII

7.7. OTHERS

  1. GLOBAL CHOLESTEROL TESTING MARKET, BY TEST TYPE

8.1. OVERVIEW

8.2. NON-INVASIVE

8.3. INVASIVE

  1. GLOBAL CHOLESTEROL TESTING MARKET, BY PRESCRIPTION MODE

9.1. OVERVIEW

9.2. OVER THE COUNTER

9.3. PRESCRIPTION BASED

  1. GLOBAL CHOLESTEROL TESTING MARKET, BY END-USERS

10.1. OVERVIEW

10.2. CLINICS

10.3. HOSPITALS

10.4. AMBULATORY CENTERS

10.5. HOMECARE

10.6. DIAGNOSTIC CENTERS

  1. GLOBAL CHOLESTEROL TESTING MARKET BY GEOGRAPHY

11.1. OVERVIEW

11.2. NORTH AMERICA

11.2.1. U.S.

11.2.2. CANADA

11.2.3. MEXICO

11.3. EUROPE

11.3.1. GERMANY

11.3.2. FRANCE

11.3.3. U.K.

11.3.4. ITALY

11.3.5. SPAIN

11.3.6. SWITZERLAND

11.3.7. NETHERLANDS

11.3.8. BELGIUM

11.3.9. RUSSIA

11.3.10. TURKEY

11.3.11. REST OF EUROPE

11.4. ASIA-PACIFIC

11.4.1. JAPAN

11.4.2. CHINA

11.4.3. INDIA

11.4.4. SOUTH KOREA

11.4.5. AUSTRALIA

11.4.6. SINGAPORE

11.4.7. THAILAND

11.4.8. MALAYSIA

11.4.9. INDONESIA

11.4.10. PHILIPPINES

11.4.11. REST OF ASIA-PACIFIC

11.5. SOUTH AMERICA

11.5.1. BRAZIL

11.5.2. REST OF SOUTH AMERICA

11.6. MIDDLE EAST AND AFRICA

11.6.1. SOUTH AFRICA

11.6.2. REST OF MIDDLE EAST AND AFRICA

  1. GLOBAL CHOLESTEROL TESTING MARKET, COMPANY LANDSCAPE

12.1. COMPANY SHARE ANALYSIS: GLOBAL

12.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3. COMPANY SHARE ANALYSIS: EUROPE

12.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

  1. COMPANY PROFILES

13.1. BIO-RAD LABORATORIES, INC.

13.1.1. COMPANY OVERVIEW

13.1.2. BIO-RAD LABORATORIES, INC.: REVENUE ANALYSIS

13.1.3. PRODUCT PORTFOLIO

13.1.4. RECENT DEVELOPMENTS

13.2. ABBOTT

13.2.1. COMPANY OVERVIEW

13.2.2. ABBOTT: REVENUE ANALYSIS

13.2.3. PRODUCT PORTFOLIO

13.2.4. RECENT DEVELOPMENTS

13.3. SIEMENS AG

13.3.1. COMPANY OVERVIEW

13.3.2. SIEMENS AG: REVENUE ANALYSIS

13.3.3. PRODUCT PORTFOLIO

13.3.4. RECENT DEVELOPMENTS

13.4. ALERE INC.

13.4.1. COMPANY OVERVIEW

13.4.2. ALERE INC.: REVENUE ANALYSIS

13.4.3. PRODUCT PORTFOLIO

13.4.4. RECENT DEVELOPMENTS

13.5. SIGMA ALDRICH (A SUBSIDIARY OF MERCK KGAA)

13.5.1. COMPANY OVERVIEW

13.5.2. MERCK KGAA: REVENUE ANALYSIS

13.5.3. PRODUCT PORTFOLIO

13.5.4. RECENT DEVELOPMENTS

13.6. F. HOFFMANN-LA ROCHE LTD

13.6.1. COMPANY OVERVIEW

13.6.2. F. HOFFMANN-LA ROCHE LTD:REVENUE ANALYSIS

13.6.3. PRODUCT PORTFOLIO

13.6.4. RECENT DEVELOPMENTS

13.7. DANAHER

13.7.1. COMPANY OVERVIEW

13.7.2. DANAHER: REVENUE ANALYSIS

13.7.3. PRODUCT PORTFOLIO

13.7.4. RECENT DEVELOPMENTS

13.8. QUEST DIAGNOSTICS INCORPORATED

13.8.1. COMPANY OVERVIEW

13.8.2. QUEST DIAGNOSTICS INCORPORATED: REVENUE ANALYSIS

13.8.3. PRODUCT PORTFOLIO

13.8.4. RECENT DEVELOPMENTS

13.9. ACCUTECH, LLC

13.9.1. COMPANY OVERVIEW

13.9.2. ACCUTECH, LLC: COMPANY SNAPSHOT

13.9.3. PRODUCT PORTFOLIO

13.9.4. RECENT DEVELOPMENTS

13.10. PRIMA LAB SA

13.10.1. COMPANY OVERVIEW

13.10.2. PRIMA LAB SA: COMPANY SNAPSHOT

13.10.3. PRODUCT PORTFOLIO

13.10.4. RECENT DEVELOPMENTS

13.11. HOME ACCESS HEALTH CORPORATION

13.11.1. COMPANY OVERVIEW

13.11.2. HOME ACCESS HEALTH CORPORATION: COMPANY SNAPSHOT

13.11.3. PRODUCT PORTFOLIO

13.11.4. RECENT DEVELOPMENTS

13.12. EUROFINS SCIENTIFIC

13.12.1. COMPANY OVERVIEW

13.12.2. EUROFINS SCIENTIFIC: REVENUE ANALYSIS

13.12.3. PRODUCT PORTFOLIO

13.12.4. RECENT DEVELOPMENTS

13.13. RANDOX LABORATORIES LTD.

13.13.1. COMPANY OVERVIEW

13.13.2. RANDOX LABORATORIES LTD.: COMPANY SNAPSHOT

13.13.3. PRODUCT PORTFOLIO

13.13.4. RECENT DEVELOPMENTS

13.14. PTS DIAGNOSTICS

13.14.1. COMPANY OVERVIEW

13.14.2. PTS DIAGNOSTIC: COMPANY SNAPSHOT

13.14.3. PRODUCT PORTFOLIO

13.14.4. RECENT DEVELOPMENTS

To Access Full Report @  https://tinyurl.com/yanydy8b

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

 

About Data Bridge Market Research

View all posts by Data Bridge Market Research →